For the year ending 2025-12-31, SCNX made $431,609 in revenue. -$41,512,264 in net income. Net profit margin of -9618.03%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | 431,609 | 136,643 | ||
| Cost of sales | 100,127 | 130,638 | ||
| Gross profit | 331,482 | 6,005 | ||
| Wage and salary expense | 2,118,568 | 2,111,066 | ||
| Professional fees | 2,407,822 | 1,458,332 | ||
| Accounting and legal expense | 2,070,337 | 1,807,041 | ||
| Technology expense | 97,261 | 416,311 | ||
| General and administrative | 7,926,016 | 6,677,580 | ||
| Research and development | 1,956,270 | 2,236,690 | ||
| Impairment loss | 26,346,050 | - | ||
| Total operating expenses | 42,922,324 | 14,707,020 | ||
| Impairment of investment | - | 2,500,000 | ||
| Operating loss | -42,590,842 | -14,701,015 | ||
| Loss on disposal of asset | - | -374,968 | ||
| Change in fair value of warrant liability | 909,020 | -182,982 | ||
| Change in fair value of derivative liability | 2,296,834 | 180,383 | ||
| Loss on conversion of note payable | -53,446 | - | ||
| Loss on disposition of subsidiaries | -288,204 | - | ||
| Interest income | 302,702 | 135,337 | ||
| Interest expense | 4,083,206 | 1,335,631 | ||
| Total non-operating expense | -916,300 | -4,077,861 | ||
| Net loss from continuing operations | -43,507,142 | - | ||
| Benefit / (provision) for income taxes | -1,994,878 | -534,396 | ||
| Net loss from continuing operations, net of tax | -41,512,264 | -18,244,480 | ||
| Net income (loss) from discontinued operations, net of tax | - | 27,310,278 | ||
| Net (loss) income | -41,512,264 | 9,065,798 | ||
| Basic EPS | -2.7 | 2.69 | ||
| Diluted EPS | -2.7 | 2.48 | ||
| Basic Average Shares | 15,347,312 | 3,375,325 | ||
| Diluted Average Shares | 15,347,312 | 3,653,609 | ||
Scienture Holdings, Inc. (SCNX)
Scienture Holdings, Inc. (SCNX)